Methods, compositions, devices, and kits for detecting mastitis

• US 20050260695A1
• Filed: 09/23/2004
• Published: 11/24/2005
• Est. Priority Date: 09/23/2003
• Status: Abandoned Application

• Current Assignee: GenPrime, Inc.
• Original Assignee: GenPrime, Inc.
• Inventors: St. Pierre, Tawyna May, Bernards, Stephanie Lynn, Fleming, James E., Somes, Jason Buck
• Application Number:
  US10/948,076
• Publication Number:
  US 20050260695A1
• Time in Patent Office: Days
• US Class Current: 435/7.930
• CPC Class Codes: G01N 2333/31 from Staphylococcus (G)
• CPC Class Codes: G01N 2333/79 Transferrins, e.g. lactoferrins, ovotransferrins
• CPC Class Codes: G01N 33/54388 based on lateral flow
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387
• CPC Class Codes: G01N 33/56938 Staphylococcus

Abstract

The present invention includes compositions, kits and methods useful for the detection of mastitis in an animal. These agents and methods are primarily directed to a method of detecting the presence of mastitis, including sub-clinical mastitis, in cows, involving incubating a sample of milk from the cow with an agent that binds to lactoferrin such as, e.g., a monoclonal antibody specific for lactoferrin, and then detecting bound lactoferrin. The invention includes lateral-flow immunoassay methods and devices for assessing the presence of lactoferrin in milk samples.

Claims

1. A device adapted for the detection of mastitis in an animal, comprising:

(a) a vessel to hold a milk sample;

(b) a first binding agent; and

(c) a second binding agent,

wherein the first binding agent binds a mastitis-associated molecule, and wherein the second binding agent comprises a detectable label.

3. The device of claim 1, wherein the second binding agent binds a mastitis-associated molecule.

4. The device of claim 3, wherein the first and/or second binding agent binds lactoferrin.

9. The device of claim 1, wherein the binding agents are antibodies specific for lactoferrin.

13. The device of claim 1, further comprising a detectable secondary agent that binds the labeled binding agent.

14. The device of claim 13, wherein the labeled binding agent is labeled with biotin, and the detectable secondary agent comprises strepavidin.

2. (canceled)

5. (canceled)

6. The method of claim 5, wherein the vessel is a solid support comprising a porous material.

8. The method of claim 5, wherein the vessel is a chromatography column.

11. The device of claim 5, wherein the solid support comprises the following components:

(a) a liquid sample application wick;

(b) a conjugate pad comprising the labeled binding agent;

(c) a base pad comprising the unlabeled binding agent;

(d) a sample pad comprising a blocking agent; and

(e) an absorbent pad.

12. The device of claim 5, further comprising a control binding agent that is immobilized in a second region of the solid support.

7. (canceled)

10. (canceled)

15. (canceled)

16. A kit adapted for the detection of mastitis in an animal, comprising:

(a) a first binding agent;

(b) a second binding agent; and

(c) instructions for the use of the kit,

wherein said first binding agent specifically bind a mastitis-associated molecule.

17. The kit of claim 16, further comprising a porous material to which a liquid sample may be applied.

18. (canceled)

19. The kit of claim 18, wherein the second binding agent comprises a label.

21. The kit of claim 19, further comprising a detectable secondary agent that binds the labeled binding agent.

22. The kit of claim 19, wherein the labeled binding agent is an antibody.

25. The kit of claim 19, wherein the labeled binding agent is labeled with biotin and the secondary agent comprises streptavidin.

20. (canceled)

23-24. -24. (canceled)

26-27. -27. (canceled)

28. A method adapted for detecting mastitis in an animal, comprising:

(a) incubating a sample of milk from an animal with a labeled binding agent that binds a mastitis-associated molecule; and

(b) detecting binding agent bound to the sample, thereby detecting mastitis in the animal.

31. The method of claim 28, wherein the binding agent is a monoclonal antibody specific for lactoferrin.

29-30. -30. (canceled)

32-36. -36. (canceled)

37. An analytical test device for detecting the presence of mastitis in an animal, comprising:

(a) a hollow casing having a liquid sample application aperture and a means permitting observation of a test result; and

(b) a test strip comprising a dry porous material contained within said hollow casing,

said test strip communicating directly or indirectly with the exterior of said hollow casing through said liquid sample application aperture to receive applied liquid sample, said test strip having a capture line observable via said means permitting observation, said test strip, in the dry unused state, containing a labeled agent capable of specifically binding lactoferrin to form a first complex of said labeled agent and said bacteria, wherein said labeled agent is dry on said test strip prior to use and is released and mobile upon application of said applied liquid sample, and

said test strip containing in said capture line a means for specifically binding said first complex, said means for binding being immobilized in said capture line;

wherein said binding means binds said first complex to form a second complex, said second complex being observable via said means permitting observation, thereby to indicate the presence of mastitis in the animal.

38. (canceled)

39. The device of claim 3637, further comprising a control line downstream from said capture line in said dry porous carrier to indicate that said liquid sample is conveyed beyond said capture line, and a control line observation aperture in said casing, said control line also being observable from outside said hollow casing through said control line observation aperture.

40. The device of claim 39, wherein said control line contains a means for binding said labeled agent and wherein said means is immobilized in said control line.

41-44. -44. (canceled)